Skip to main content
TipRanks
Go Ultimate75% OFF

Michael John Bassett Insider Profile

4 Followers

Michael John Bassett, Director at OncoSil Medical Ltd, holds 1.12M shares in OncoSil Medical Ltd (Ticker: AU:OSL). Most recently, Michael John Bassett Bought 93,000 shares of OncoSil Medical Ltd on May 29, 2020 for an estimated value of AU$8.37K.

Michael John Bassett's Trading History

OSL
OncoSil Medical Ltd
May 29, 2020DirectorInformative Buy8.37KAU$719.82K
AU:OSL
Insider Shares: 1.12M (17.98%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 29, 2020Informative BuyAU$8.37K93,000AU$0.09-24.70%―
May 03, 2019Informative BuyAU$44.24K800,000AU$0.06+48.60%―

You May Also Like

Michael John Bassett insider profile FAQ

What is the percentage of profitable transactions made by Michael John Bassett?
The percentage of profitable transactions made by Michael John Bassett is 50%.
What is the average return per transaction made by Michael John Bassett?
The average return per transaction made by Michael John Bassett is 11.90%.
What stocks does Michael John Bassett hold?
Michael John Bassett holds: AU:OSL stocks.
What was Michael John Bassett’s latest transaction?
Michael John Bassett’s latest transaction was an Informative Buy of AU$8.37K.
What was Michael John Bassett's most profitable transaction?
Michael John Bassett’s most profitable transaction was an Informative Buy of AU:OSL stock on May 3, 2019. The return on the trade was 48.60%.
What is Michael John Bassett's role in OncoSil Medical Ltd?
Michael John Bassett's role in OncoSil Medical Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.